Home

bild Chip Räta ut multiple sclerosis nature programvara Uppskatta OPPONENT

Multiple sclerosis enters a grey area
Multiple sclerosis enters a grey area

Neural stem cell transplantation in patients with progressive multiple  sclerosis: an open-label, phase 1 study | Nature Medicine
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study | Nature Medicine

When encephalitogenic T cells collaborate with microglia in multiple  sclerosis | Nature Reviews Neurology
When encephalitogenic T cells collaborate with microglia in multiple sclerosis | Nature Reviews Neurology

Frontiers | Multiple Sclerosis as a Syndrome—Implications for Future  Management
Frontiers | Multiple Sclerosis as a Syndrome—Implications for Future Management

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Mechanism-based criteria to improve therapeutic outcomes in progressive multiple  sclerosis | Nature Reviews Neurology
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology

Mechanism-based criteria to improve therapeutic outcomes in progressive multiple  sclerosis | Nature Reviews Neurology
Mechanism-based criteria to improve therapeutic outcomes in progressive multiple sclerosis | Nature Reviews Neurology

Multiple sclerosis | Nature Reviews Disease Primers
Multiple sclerosis | Nature Reviews Disease Primers

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Transcriptional analysis of targets in multiple sclerosis | Nature Reviews  Immunology
Transcriptional analysis of targets in multiple sclerosis | Nature Reviews Immunology

Fingolimod (FTY720): discovery and development of an oral drug to treat multiple  sclerosis | Nature Reviews Drug Discovery
Fingolimod (FTY720): discovery and development of an oral drug to treat multiple sclerosis | Nature Reviews Drug Discovery

Neuronal vulnerability and multilineage diversity in multiple sclerosis |  Nature
Neuronal vulnerability and multilineage diversity in multiple sclerosis | Nature

Progressive multiple sclerosis: from pathophysiology to therapeutic  strategies | Nature Reviews Drug Discovery
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery

Multiple sclerosis | Nature Reviews Disease Primers
Multiple sclerosis | Nature Reviews Disease Primers

The immunology of multiple sclerosis | Nature Reviews Immunology
The immunology of multiple sclerosis | Nature Reviews Immunology

Immune-cell crosstalk in multiple sclerosis
Immune-cell crosstalk in multiple sclerosis

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Progressive multiple sclerosis: from pathophysiology to therapeutic  strategies | Nature Reviews Drug Discovery
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies | Nature Reviews Drug Discovery

Immunopathology of multiple sclerosis | Nature Reviews Immunology
Immunopathology of multiple sclerosis | Nature Reviews Immunology

Multiple sclerosis - The Lancet
Multiple sclerosis - The Lancet

New concepts in the immunopathogenesis of multiple sclerosis | Nature  Reviews Neuroscience
New concepts in the immunopathogenesis of multiple sclerosis | Nature Reviews Neuroscience

The immunology of multiple sclerosis | Nature Reviews Immunology
The immunology of multiple sclerosis | Nature Reviews Immunology